Cargando…
The ATLAS Randomised Clinical Trial: What do the Superiority Results Mean for Subcutaneous ICD Therapy and Sudden Cardiac Death Prevention as a Whole?
This review sets out the key evidence comparing subcutaneous ICDs (S-ICDs) and transvenous ICDs and uses it to empower clinical cardiologists and those who implant ICDs to make optimum patient selections for S-ICD use. The evidence demonstrates that clinical trials performed until recently have prov...
Autor principal: | Rordorf, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611761/ https://www.ncbi.nlm.nih.gov/pubmed/36313240 http://dx.doi.org/10.15420/aer.2022.11.S1 |
Ejemplares similares
-
Transvenous lead implantation via the accessory hemiazygos vein in superior vena cava occlusion
por: Waddingham, Peter H., et al.
Publicado: (2021) -
Cardiac resynchronization therapy with multipoint pacing via quadripolar lead versus traditional biventricular pacing: A systematic review and meta-analysis of clinical studies on hemodynamic, clinical, and prognostic parameters
por: Massacesi, Cristiano, et al.
Publicado: (2021) -
Long-term clinical outcomes after upgrade to resynchronization therapy: A propensity score–matched analysis
por: Brandão, Mariana, et al.
Publicado: (2021) -
Heart failure treatment in patients with cardiac implantable electronic devices: Opportunity for improvement
por: Salimian, Samaneh, et al.
Publicado: (2021) -
Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)